Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells
- 1 September 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (18) , 1363-1371
- https://doi.org/10.1038/sj.gt.3301531
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 33 references indexed in Scilit:
- An Adenovirus Encoding Proapoptotic Bax Induces Apoptosis and Enhances the Radiation Effect in Human Ovarian CancerMolecular Therapy, 2000
- Cre-loxP-mediated bax gene activation reduces growth rate and increases sensitivity to chemotherapeutic agents in human gastric cancer cellsCancer Gene Therapy, 2000
- Adenoviral vector which delivers FasL–GFP fusion protein regulated by the tet-inducible expression systemGene Therapy, 2000
- A binary adenoviral vector system for expressing high levels of the proapoptotic gene baxGene Therapy, 2000
- Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of BaxOncogene, 1999
- Bcl-2–Mediated Drug ResistanceThe Journal of Experimental Medicine, 1999
- Human p53-p51 (p53-Related) Fusion Protein: A PotentBAXTransactivatorJapanese Journal of Cancer Research, 1999
- Apoptin: nuclear switch triggers cancer cell deathGene Therapy, 1999
- Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of ApoptosisScience, 1998
- Antitumor Activity of bax and p53 Naked Gene Transfer in Lung Cancer: In Vitro and In Vivo AnalysisHuman Gene Therapy, 1998